Labd etf.

View Top Holdings and Key Holding Information for Direxion Daily S&P Biotech Bear 3X Shares (LABD).Here is a list of seven top biotech ETFs to buy in 2022. Ark Genomics Revolution ETF ( ARKG) Cathie Wood’s flagship ARKG ETF suffered dearly in recent years, falling more than 30% in 2021 and 54 ...Ideas. Direxion Daily S&P Biotech Bear 3X Shares (LABD) On daily chart, LABD is trading in an uptrend, and by Friday’s session, LABD has broken major resistance that lies on 29.19$, and the confirmation of that breakout, will trigger LABD witness further rises near to 31.72 – 34.20 – 41.40 – 42.71 om short term basis.Saving for retirement is something that is very important but knowing the right things to invest in to ensure the money grows can be difficult. A diversified portfolio is an excellent way to invest for the future, and this can be accessed t...

Oct 10, 2023 · The U.S. economy added 336,000 jobs in September 2023, well above an upwardly revised 227,000 in August, and beating market forecasts of 170,000. It marked the strongest job gain in eight months ... Direxion Daily S&P 500® Bear 3X Shares ETF (SPXS) is a widely used tool for hedging portfolios and shorting the market. Click for my review of the SPXS ETF. ... GLD, GLL, IWM, LABD, LABU, QQQ ...

The short couple would be down by 1.34%. LABU vs. LABD 1-Month (Seeking Alpha) Over the six months, LABU is down by 18.68% and LABD is down by 5.67%. The short couple would be up by 12.175%. LABU ...

LABD Daily S&P Biotech Bear 3X Shares -300% Financial Select Sector Index (IXMTR) FAS Daily Financial Bull 3X Shares 300% FAZ Daily Financial Bear 3X Shares -300% Health Care Select Sector Index (IXVTR) ... The non-leveraged ETFs may invest in a relatively small number of issuers and, as a result, be subject to greater risk of loss with …Another ETF, iShares Biotechnology ETF , is a cap-weighted of 276 all-cap biotechnology stocks. Over a very long time, the two ETFs have about identical returns.Nov 23, 2023 · LABD – Direxion Daily S&P Biotech Bear 3X ETF – Check LABD price, review total assets, see historical growth, and review the analyst rating from Morningstar. The ETF was one of the top performing levered ETFs returning ~31% in the last week. 7. FAZ – Direxion Daily Financial Bear 3X Shares. FAZ, which offers 3x daily short leverage to the Russell ...

Dec 1, 2023 · These leveraged ETFs seek a return that is 300% or -300% of the return of their benchmark index for a single day. The funds should not be expected to provide three times or negative three times the return of the benchmark’s cumulative return for periods greater than a day.

Stock Price. Open: 17.07 ; Volume. Stock: 8,967,007 ; Volatility. Today's Stock Vol: 159.3 ; Corporate. Dividend: 19-Dec $0.0918 (Est.) ; Descriptive. Type: ETF.

Nov 14, 2023 · MSOX – AdvisorShares MSOS 2x Daily ETF. MSOX, which seeks to achieve 2x the total daily return of the AdvisorShares Pure US Cannabis ETF (MSOS) through swap agreements featured on the list with a 24% weekly return, as chances of federal legalization seem better. 4. LABD – Direxion Daily S&P Biotech Bear 3x Shares LABD LABU. LABD. LABU. The Direxion Daily S&P Biotech Bull and Bear 3X Shares seek daily investment results, before fees and expenses, of 300%, or 300% of the inverse (or opposite), of the performance of the S&P Biotechnology Select Industry Index. There is no guarantee the funds will achieve their stated investment objectives.Direxion Daily S&P Biotech Bear 3X ETF. LABD NYSEARCA. 18.93. -0.55. -2.82%. After Hours: 18.95 +0.02 +0.11% 19:59 11/22 EST. OPEN. 18.85. DAY'S RANGE.LABD LABU. LABD. LABU. The Direxion Daily S&P Biotech Bull and Bear 3X Shares seek daily investment results, before fees and expenses, of 300%, or 300% of the inverse (or opposite), of the performance of the S&P Biotechnology Select Industry Index. There is no guarantee the funds will achieve their stated investment objectives.Nov 13, 2023 · LABD LABU. LABD. LABU. The Direxion Daily S&P Biotech Bull and Bear 3X Shares seek daily investment results, before fees and expenses, of 300%, or 300% of the inverse (or opposite), of the performance of the S&P Biotechnology Select Industry Index. There is no guarantee the funds will achieve their stated investment objectives.

Holdings. Compare ETFs LABD and CARD on performance, AUM, flows, holdings, costs and ESG ratings.Nov 23, 2023 · LABD ETF Database Category Average FactSet Segment Average; Number of Holdings 1 3 1 % of Assets in Top 10 100.00% 91.24% 100.00% % of Assets in Top 15 LABD – Direxion Daily S&P Biotech Bear 3x Shares LABD , which offers inverse exposure to the US Biotechnology sector, gained by 10% last week on concerns about future interest rate hikes. 10.Wall Street was downbeat last week. Each of the key equity gadgets -- the S&P 500 (down 0.7%), the Dow Jones (down 0.01.%), the Nasdaq Composite (down 1.6%) and the Russell 2000 (down 1.8% ...The Fund, under normal circumstances, invests at least 80% of the Fund’s net assets (plus borrowing for investment purposes) in swap agreements, futures contracts, short positions or other financial instruments that provide inverse (opposite) or short daily exposure to the Index or to ETFs that track the Index, which, in combination, provider ... Go To: Full Chart Realtime quote and/or trades are not sourced from all markets. Fund Basics Fund Family Direxion Investments Assets Under Management 70,296,700 …Holdings. Compare ETFs SPY and LABD on performance, AUM, flows, holdings, costs and ESG ratings.

Inverse/Leveraged Biotech. Direxion Daily S&P Biotech Bear 3x Shares LABD – Up 32.1%. Growth sectors like biotech underperform in a rising rate environment. The fact explains the rally in ...LABD charges investors 95 bps in annual fees and gained 19% last month (read: Moderna ETFs Rallying on COVID-19 Vaccine News to Combat Omicron). MicroSectors U.S. Big Oil Index -3X Inverse ...

LABU And LABD: Another Attractive Double-Short Pairs Trade. TNA And TZA: Shorting Both Produces An Attractive Pairs Trade. TZA: Tempting To Time, But Avoid It. LABU, BOIL and DUST among weekly ETF ...Jul 8, 2022 · LABU and LABD were created on 5/28/2015. The daily returns of LABU are approximately 3X the returns of XBI. LABD is an inverse 3X leveraged ETF, and its daily returns are about -3X the returns of XBI. LABU, TZA and LABD among weekly ETF movers. Gainers: Direxion Daily Regional Banks Bull 3X Shares ( DPST) +28%. Direxion Daily S&P Biotech Bull 3x Shares ETF ( NYSEARCA: LABU) +26%. MicroSectors U ...This led to a crash in biotech stocks and ETFs and the below-mentioned inverse/leveraged ETF won. S&P Biotech Bear 3X Direxion LABD – Up 24.2%. Inverse/Leveraged Technology. The tech-heavy Nasdaq posted its biggest daily drop since February after the hawkish Fed minutes on Jan 5. Since the index is high-growth in …LABU, TZA and LABD among weekly ETF movers. Gainers: Direxion Daily Regional Banks Bull 3X Shares ( DPST) +28%. Direxion Daily S&P Biotech Bull 3x Shares ETF ( NYSEARCA: LABU) +26%. MicroSectors U ...Dec 1, 2023 · The Direxion Daily S&P Biotech Bear 3X Shares fund seeks daily investment results, before fees and expenses, of 300% of the inverse of the performance of the S&P Biotechnology Select Industry Index. Direxion Daily S&P Biotech Bear 3X Shares (LABD): ETF Research Reports Direxion Daily S&P Oil & Gas Exp. & Prod. Bear 2X Shares (DRIP): ETF Research Reports MicroSectors Oil & Gas E&P 3x Inverse Leveraged ETNs (OILD): ETF Research Reports MicroSectors U.S. Big Oil Index 3X Inverse Leveraged ETN (NRGD): ETF Research …Direxion Shares ETF Trust - Daily S&P Biotech Bear 3X Shs (LABD) has 3 splits in our LABD split history database. The first split for LABD took place on ...Nov 14, 2023 · MSOX – AdvisorShares MSOS 2x Daily ETF. MSOX, which seeks to achieve 2x the total daily return of the AdvisorShares Pure US Cannabis ETF (MSOS) through swap agreements featured on the list with a 24% weekly return, as chances of federal legalization seem better. 4. LABD – Direxion Daily S&P Biotech Bear 3x Shares

LABD charges investors 94 bps in annual fees. ProShares UltraPro Short QQQ (SQQQ) - Up 14.7% ProShares UltraPro Short QQQ provides three times inverse exposure to the daily performance of the ...

The biotech fund, LABD, which offers inverse exposure to the US Biotechnology sector, gained by over 19% last week, with the healthcare sector registering a fall of over 1% and biotech was down ~3 ...

S&P Biotech Bear -3X Direxion (LABD) – Up 8.8% The space has been struggling for quite some time now. Due to higher rates, absence of cheaper capital and ebbing pandemic, the initial public ...LABD charges investors 95 bps in annual fees and gained 19% last month (read: Moderna ETFs Rallying on COVID-19 Vaccine News to Combat Omicron). MicroSectors U.S. Big Oil Index -3X Inverse ...May 28, 2015 · LABD is a US Equities ETF. The Fund seeks daily investment results, before fees and expenses, of 300% of the inverse (or opposite) of the performance of the S&P Biotechnology Select Industry Index. The Index is provided by Standard & Poor s and includes domestic companies from the biotechnology industry. Jan 25, 2022 · ProShares Ultra VIX Short-Term Futures ETF: 40.07% (LABD ) Direxion Daily S&P Biotech Bear 3x Shares: 35.04% : Direxion Daily S&P 500 High Beta Bear 3X Shares: 30.50% : ProShares Ultra VIX Short-Term Futures ETF (UVXY) – Up 21.6% ProShares Ultra VIX Short-Term Futures ETF offers exposure to one and one-half times (1.5X) the daily performance of the S&P 500 VIX ...OILD ETF, which provides exposure to the inverse performance of U.S. oil, gas, and consumable fuels, ... LABD – Direxion Daily S&P Biotech Bear 3x Shares. The biotech fund, ...Please contact [email protected] if you have any further questions. Learn everything about Direxion Daily S&P Biotech Bear 3X Shares (LABD). Free ratings, analyses, holdings, benchmarks, quotes, and ...My “Drift” is the drift of a leveraged ETF normalized to the underlying index exposure in a time interval. It is calculated as follows: Drift = (Return - (IndexReturn x Ñ))/ Abs (Ñ) “Decay ...AdvisorShares MSOS 2x Daily ETF, MicroSectors U.S. Big Oil Index 3X Leveraged ETN, Direxion Daily 20+ Year Treasury Bear 3x Shares, MAX Airlines -3X Inverse Leveraged ETN and Direxion Daily S&P ...Direxion 每日三倍放空標普500生技ETF(LABD)主要追蹤指數為S&P Biotechnology Select Industry Index，ETF LABD成分股有哪些？我們提供完整的LABD持股明細、成分股 ...

The appeal for leveraged and inverse-leveraged ETFs has increased as these fetch outsized returns on quick market turns in a short span.More up-to-date holdings information may be available on the sponsor’s website. LABD: Direxion Daily S&P Biotech Bear 3X Shares - Fund Holdings. Get up to date fund holdings for Direxion Daily S ...Inverse ETFs gained as stocks declined, driven by a fall in the jobless claims data, which led to rate hike jitters. 10. LABD – Direxion Daily S&P Biotech Bear 3x Shares.Heather Bell | Mar 28, 2016. Learn everything about Direxion Daily S&P Biotech Bull 3X Shares (LABU). Free ratings, analyses, holdings, benchmarks, quotes, and news.Instagram:https://instagram. e8 funding reviewsbest small cap index fundregional bank etfsonline futures broker LABD: Direxion Daily S&P Biotech Bear 3X Shares: S&P Biotechnology Select Industry Index (SPSIBITR)-300%: Download: LABU: Direxion Daily S&P Biotech Bull 3X Shares: S&P Biotechnology Select Industry Index (SPSIBITR) 300%: Download: SOXS: ... The ETFs do not attempt to, and should not be expected to, provide returns which are a multiple of …Corporate Bond ETFs ; High Yield Bond ETFs ; Muni National Short-Term Bond ETFs ; Muni National Intermediate-Term Bond ETFs ; Muni National Long-Term … dividend and yieldthematic funds Inverse ETFs Up More Than 50% YTD. Here we highlight some Inverse ETFs that are up more than 50% so far in 2022. ... Direxion Daily S&P Biotech Bear 3X Shares LABD — up 83.1% year to date. best crypto algo trading platform LABD | A complete Direxion Daily S&P Biotech Bear 3X Shares exchange traded fund overview by MarketWatch. View the latest ETF prices and news for better ETF investing. LABD. LABU. The Direxion Daily S&P Biotech Bull and Bear 3X Shares seek daily investment results, before fees and expenses, of 300%, or 300% of the inverse (or opposite), of the performance of the S&P Biotechnology Select Industry Index. There is no guarantee the funds will meet their stated investment objectives.